<DOC>
	<DOCNO>NCT00404300</DOCNO>
	<brief_summary>An open , multi-centre study patient von Willebrand Disease ( VWD ) undergo surgery .</brief_summary>
	<brief_title>Optivate People With Von Willebrand Disease Undergoing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>1 . Have give write informed consent . 2 . Be age 12 year old . 3 . Have VWD know type . 4 . Be due undergo surgery , investigator believe VWF concentrate require . 5 . Have know lack , poor response , contraindication , DDAVP , require type surgery plasmaderived product appropriate . 6 . Have prothrombin time ( PT ) 3 second upper limit reference range . 7 . Female patient childbearing potential , exception pregnant patient undergo Caesarean surgery mode delivery , include normal vaginal delivery , must negative result human chorionic gonadotropinbased pregnancy test . If female patient become sexually active , must practice contraception use method proven reliability duration study . 1 . Have history inhibitor development VWF FVIII positive result screening ( positive screen VWF inhibitor ; positive screen result &gt; 0.5 BU FVIII inhibitor ) . A result screen mandatory patient undergo emergency surgery local laboratory unable perform analysis . 2 . Patients thrombocytopenia ( platelet &lt; 50 x 109/L ) . 3 . Patients clinically significant renal disease ( creatinine &gt; 200 Âµmol/L ) . 4 . Patients clinically significant liver disease ( ALT level great three time upper limit reference range ) . 5 . Presence major systemic illness would compromise outcome study opinion investigator . 6 . Known suspected hypersensitivity investigational medicinal product ( IMP ) excipients . 7 . Have recent history alcohol drug abuse . 8 . Administration new chemical entity within 4 month precede enrolment . 9 . Participation clinical study investigational market drug employ 30 day precede enrolment ( screen visit ) study , exception BPL clinical study Protocol 8VWF01 . 10 . Female patient lactate . 11 . In opinion investigator , patient unlikely comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>